XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   1,250        
Beginning balance at Dec. 31, 2021 $ 179,746,436 $ 1 $ 70,359 $ 351,033,589 $ 0 $ (171,357,513)
Beginning balance (in shares) at Dec. 31, 2021     70,364,912      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)     52,333      
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan 33,079   $ 14 33,065    
Stock-based compensation expense 1,324,812     1,324,812    
Net (loss) income (16,108,056)         (16,108,056)
Ending balance (in shares) at Mar. 31, 2022   1,250        
Ending balance at Mar. 31, 2022 164,996,271 $ 1 $ 70,373 352,391,466 0 (187,465,569)
Ending balance (in shares) at Mar. 31, 2022     70,417,245      
Beginning balance (in shares) at Dec. 31, 2021   1,250        
Beginning balance at Dec. 31, 2021 179,746,436 $ 1 $ 70,359 351,033,589 0 (171,357,513)
Beginning balance (in shares) at Dec. 31, 2021     70,364,912      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (30,696,470)          
Ending balance (in shares) at Jun. 30, 2022   1,250        
Ending balance at Jun. 30, 2022 152,147,496 $ 1 $ 70,414 354,221,191 (90,127) (202,053,983)
Ending balance (in shares) at Jun. 30, 2022     70,419,388      
Beginning balance (in shares) at Mar. 31, 2022   1,250        
Beginning balance at Mar. 31, 2022 164,996,271 $ 1 $ 70,373 352,391,466 0 (187,465,569)
Beginning balance (in shares) at Mar. 31, 2022     70,417,245      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)     2,143      
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan 109,548   $ 41 109,507    
Stock-based compensation expense 1,720,217     1,720,217    
Other comprehensive income (90,127)       (90,127)  
Net (loss) income (14,588,414)         (14,588,414)
Ending balance (in shares) at Jun. 30, 2022   1,250        
Ending balance at Jun. 30, 2022 $ 152,147,496 $ 1 $ 70,414 354,221,191 (90,127) (202,053,983)
Ending balance (in shares) at Jun. 30, 2022     70,419,388      
Beginning balance (in shares) at Dec. 31, 2022 1,250 1,250        
Beginning balance at Dec. 31, 2022 $ 132,272,564 $ 1 $ 70,467 357,770,825 (42,187) (225,526,542)
Beginning balance (in shares) at Dec. 31, 2022 70,466,885   70,466,885      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)     24,625      
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan $ 66,993   $ 25 66,968    
Stock-based compensation expense 1,916,518     1,916,518    
Other comprehensive income 47,817       47,817  
Net (loss) income (13,356,209)         (13,356,209)
Ending balance (in shares) at Mar. 31, 2023   1,250        
Ending balance at Mar. 31, 2023 $ 120,947,682 $ 1 $ 70,492 359,754,310 5,630 (238,882,751)
Ending balance (in shares) at Mar. 31, 2023     70,491,510      
Beginning balance (in shares) at Dec. 31, 2022 1,250 1,250        
Beginning balance at Dec. 31, 2022 $ 132,272,564 $ 1 $ 70,467 357,770,825 (42,187) (225,526,542)
Beginning balance (in shares) at Dec. 31, 2022 70,466,885   70,466,885      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income $ (25,764,539)          
Ending balance (in shares) at Jun. 30, 2023 1,250 1,250        
Ending balance at Jun. 30, 2023 $ 110,698,675 $ 1 $ 70,603 361,913,944 5,208 (251,291,081)
Ending balance (in shares) at Jun. 30, 2023 70,602,793   70,603,793      
Beginning balance (in shares) at Mar. 31, 2023   1,250        
Beginning balance at Mar. 31, 2023 $ 120,947,682 $ 1 $ 70,492 359,754,310 5,630 (238,882,751)
Beginning balance (in shares) at Mar. 31, 2023     70,491,510      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)     112,283      
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan 211,097   $ 111 210,986    
Stock-based compensation expense 1,948,648     1,948,648    
Other comprehensive income (422)       (422)  
Net (loss) income $ (12,408,330)          
Ending balance (in shares) at Jun. 30, 2023 1,250 1,250        
Ending balance at Jun. 30, 2023 $ 110,698,675 $ 1 $ 70,603 $ 361,913,944 $ 5,208 $ (251,291,081)
Ending balance (in shares) at Jun. 30, 2023 70,602,793   70,603,793